Surface mineralization of Ti6Al4V substrates with calcium apatites for the retention and local delivery of recombinant human bone morphogenetic protein-2

被引:15
作者
Liu, Pingsheng [1 ]
Smits, Jonathan [1 ]
Ayers, David C. [1 ]
Song, Jie [1 ,2 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
关键词
Biomineralization; Titanium alloys; Recombinant human bone morphogenetic protein-2; Osteoinductivity; Calcium apatite; IN-VITRO; HYDROXYAPATITE COATINGS; CELL-ADHESION; TITANIUM; IMPLANTS; COMPOSITES; SCAFFOLDS; PHOSPHATE; POROSITY; ALLOYS;
D O I
10.1016/j.actbio.2011.05.025
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Titanium alloys are prevalently used as orthopedic prosthetics. Inadequate bone-implant interactions can lead to premature prosthetic loosening and implant failure. Local delivery of osteogenic therapeutics promoting osteointegration of the implant is an attractive strategy to address this clinical challenge. Given the affinity of calcium apatites for bone matrix proteins we hypothesize that titanium alloys surface mineralized with calcium apatites should be explored for the retention and local delivery of osteogenic recombinant human bone morphogenetic protein-2 (rhBMP-2). Using a heterogeneous surface nucleation and growth process driven by the gradual pH elevation of an acidic solution of hydroxyapatite via thermal decomposition of urea, Ti6Al4V substrates were surface mineralized with calcium apatite domains exhibiting good affinity for the substrate. The microstructures, size and surface coverage of the mineral domains as a function of the in vitro mineralization conditions were examined by light and scanning electron microscopy and the surface calcium ion content quantified. An optimal mineralization condition was identified to rapidly (<10 h) achieve surface mineral coverage far superior to those accomplished by week long incubation in simulated body fluids. In vitro retention-release profiles of rhBMP-2 from the mineralized and unmineralized Ti6Al4V, determined by an enzyme-linked immunosorbent assay, supported a higher degree of retention of rhBMP-2 on the mineralized substrate. The rhBMP-2 retained on the mineralized substrate after 24 h incubation in phosphate-buffered saline remained bioactive, as indicated by its ability to induce osteogenic transdifferentiation of C2C12 myoblasts attached to the substrate. This mineralization technique could also be applied to the surface mineralization of calcium apatites on dense tantalum and titanium and porous titanium substrates. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:3488 / 3495
页数:8
相关论文
共 31 条
  • [1] Influence of porosity on mechanical properties and in vivo response of Ti6Al4V implants
    Bandyopadhyay, Amit
    Espana, Felix
    Balla, Vamsi Krishna
    Bose, Susmita
    Ohgami, Yusuke
    Davies, Neal M.
    [J]. ACTA BIOMATERIALIA, 2010, 6 (04) : 1640 - 1648
  • [2] Influence of anodization on the adhesion of calcium phosphate coatings on titanium substrates
    Blackwood, Daniel J.
    Seah, Kar Heng W.
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 93A (04) : 1551 - 1556
  • [3] Filion TM, 2011, TISSUE ENG PT A, V17, P503, DOI [10.1089/ten.tea.2010.0274, 10.1089/ten.TEA.2010.0274]
  • [4] Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion
    Gilbert, M
    Shaw, WJ
    Long, JR
    Nelson, K
    Drobny, GP
    Giachelli, CM
    Stayton, PS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) : 16213 - 16218
  • [5] Han Y, 2001, J BIOMED MATER RES, V54, P96, DOI 10.1002/1097-4636(200101)54:1<96::AID-JBM11>3.0.CO
  • [6] 2-U
  • [7] Cellular Ti-6Al-4V structures with interconnected macro porosity for bone implants fabricated by selective electron beam melting
    Heinl, Peter
    Mueller, Lenka
    Koerner, Carolin
    Singer, Robert F.
    Mueller, Frank A.
    [J]. ACTA BIOMATERIALIA, 2008, 4 (05) : 1536 - 1544
  • [8] BONE MORPHOGENETIC PROTEIN-2 CONVERTS THE DIFFERENTIATION PATHWAY OF C2C12 MYOBLASTS INTO THE OSTEOBLAST LINEAGE
    KATAGIRI, T
    YAMAGUCHI, A
    KOMAKI, M
    ABE, E
    TAKAHASHI, N
    IKEDA, T
    ROSEN, V
    WOZNEY, JM
    FUJISAWASEHARA, A
    SUDA, T
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 127 (06) : 1755 - 1766
  • [9] Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO
  • [10] 2-B